Jia Xiang
Directeur Financier/CFO chez HaploX Investment Holding Ltd.
Postes actifs de Jia Xiang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Directeur Financier/CFO | - | - |
| Secrétaire Général | - | - |
Historique de carrière de Jia Xiang
Anciens postes connus de Jia Xiang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Hydroelectric Corp. | Corporate Officer/Principal | 01/03/2015 | 01/01/2016 |
Formation de Jia Xiang
| Shanghai Jiao Tong University | Graduate Degree |
Statistiques
Internationale
| Îles Cayman | 2 |
| Etats-Unis | 2 |
| Chine | 2 |
Opérationnelle
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Commercial Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
| Hydroelectric Corp. |
